- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 62.5%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -1.36 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | -0.60 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | 1.60 | 321.05 | 1.00 | 0 | 0.00 | 0 | 62.50 | 0 | 0.00 | 0 | 62.50 | 0 |
| 2020 (7) | 0.38 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | -0.89 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | -0.94 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | -0.03 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | -0.91 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.01 | -116.67 | 94.44 | 0.02 | -60.0 | 107.69 | -0.12 | -9.09 | 90.55 |
| 24Q2 (19) | 0.06 | 135.29 | 115.0 | 0.05 | 123.81 | 111.36 | -0.11 | 35.29 | 90.0 |
| 24Q1 (18) | -0.17 | -88.89 | 75.36 | -0.21 | -2200.0 | 65.0 | -0.17 | 87.5 | 75.36 |
| 23Q4 (17) | -0.09 | 50.0 | 85.48 | 0.01 | 103.85 | 102.08 | -1.36 | -7.09 | -126.67 |
| 23Q3 (16) | -0.18 | 55.0 | 55.0 | -0.26 | 40.91 | 63.38 | -1.27 | -15.45 | -6450.0 |
| 23Q2 (15) | -0.40 | 42.03 | -1433.33 | -0.44 | 26.67 | -100.0 | -1.10 | -59.42 | -361.9 |
| 23Q1 (14) | -0.69 | -11.29 | -276.92 | -0.60 | -25.0 | -293.55 | -0.69 | -15.0 | -276.92 |
| 22Q4 (13) | -0.62 | -55.0 | -287.88 | -0.48 | 32.39 | -245.45 | -0.60 | -3100.0 | -137.5 |
| 22Q3 (12) | -0.40 | -1433.33 | -197.56 | -0.71 | -222.73 | -216.39 | 0.02 | -95.24 | -98.43 |
| 22Q2 (11) | 0.03 | -92.31 | -94.0 | -0.22 | -170.97 | -136.67 | 0.42 | 7.69 | -51.16 |
| 22Q1 (10) | 0.39 | 18.18 | 8.33 | 0.31 | -6.06 | -26.19 | 0.39 | -75.62 | 8.33 |
| 21Q4 (9) | 0.33 | -19.51 | -8.33 | 0.33 | -45.9 | 3.13 | 1.60 | 25.98 | 321.05 |
| 21Q3 (8) | 0.41 | -18.0 | -12.77 | 0.61 | 1.67 | 90.62 | 1.27 | 47.67 | 6250.0 |
| 21Q2 (7) | 0.50 | 38.89 | 242.86 | 0.60 | 42.86 | 225.0 | 0.86 | 138.89 | 286.96 |
| 21Q1 (6) | 0.36 | 0.0 | 427.27 | 0.42 | 31.25 | 4300.0 | 0.36 | -5.26 | 427.27 |
| 20Q4 (5) | 0.36 | -23.4 | 146.75 | 0.32 | 0.0 | 196.97 | 0.38 | 1800.0 | 142.7 |
| 20Q3 (4) | 0.47 | 234.29 | 0.0 | 0.32 | 166.67 | 0.0 | 0.02 | 104.35 | 0.0 |
| 20Q2 (3) | -0.35 | -218.18 | 0.0 | -0.48 | -4700.0 | 0.0 | -0.46 | -318.18 | 0.0 |
| 20Q1 (2) | -0.11 | 85.71 | 0.0 | -0.01 | 96.97 | 0.0 | -0.11 | 87.64 | 0.0 |
| 19Q4 (1) | -0.77 | 0.0 | 0.0 | -0.33 | 0.0 | 0.0 | -0.89 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 2.7 | -16.43 | 22.73 | 26.88 | 20.83 | 8.63 | N/A | - | ||
| 2024/10 | 3.23 | 19.21 | 32.46 | 24.18 | 20.62 | 8.76 | N/A | - | ||
| 2024/9 | 2.71 | -4.14 | 11.62 | 20.95 | 18.98 | 8.06 | 0.87 | - | ||
| 2024/8 | 2.82 | 11.74 | 41.5 | 18.24 | 20.16 | 7.64 | 0.91 | - | ||
| 2024/7 | 2.53 | 10.57 | 21.26 | 15.42 | 16.93 | 7.42 | 0.94 | - | ||
| 2024/6 | 2.29 | -12.38 | 11.36 | 12.89 | 16.11 | 6.95 | 1.06 | - | ||
| 2024/5 | 2.61 | 26.78 | 17.78 | 10.6 | 17.19 | 6.99 | 1.05 | - | ||
| 2024/4 | 2.06 | -11.18 | 19.07 | 7.99 | 17.0 | 5.91 | 1.24 | - | ||
| 2024/3 | 2.32 | 50.96 | 9.15 | 5.94 | 16.3 | 5.94 | 1.15 | - | ||
| 2024/2 | 1.54 | -26.31 | -7.37 | 3.62 | 21.39 | 5.91 | 1.15 | - | ||
| 2024/1 | 2.08 | -8.94 | 57.44 | 2.08 | 57.44 | 6.57 | 1.04 | 因11３年１月營業天數較去年同期增加所致 | ||
| 2023/12 | 2.29 | 4.09 | 7.25 | 24.53 | -11.91 | 6.92 | 1.02 | - | ||
| 2023/11 | 2.2 | -9.81 | 1.72 | 22.24 | -13.5 | 7.06 | 1.0 | - | ||
| 2023/10 | 2.44 | 0.46 | 51.18 | 20.04 | -14.89 | 6.86 | 1.03 | 主要為子公司營收增加影響 | ||
| 2023/9 | 2.43 | 21.51 | 13.91 | 17.61 | -19.75 | 6.51 | 1.15 | - | ||
| 2023/8 | 2.0 | -4.24 | -7.22 | 15.18 | -23.36 | 6.13 | 1.22 | - | ||
| 2023/7 | 2.08 | 1.54 | -8.8 | 13.19 | -25.33 | 6.35 | 1.17 | - | ||
| 2023/6 | 2.05 | -7.33 | -12.48 | 11.1 | -27.79 | 6.0 | 1.26 | - | ||
| 2023/5 | 2.22 | 28.17 | -2.13 | 9.05 | -30.55 | 6.07 | 1.25 | - | ||
| 2023/4 | 1.73 | -18.57 | -35.25 | 6.83 | -36.52 | 5.51 | 1.37 | - | ||
| 2023/3 | 2.12 | 28.09 | -33.47 | 5.1 | -36.94 | 5.1 | 1.49 | - | ||
| 2023/2 | 1.66 | 25.25 | -21.58 | 2.98 | -39.2 | 5.11 | 1.48 | - | ||
| 2023/1 | 1.32 | -37.97 | -52.56 | 1.32 | -52.56 | 5.62 | 1.35 | 主因為112年1月營業天數較去年同期減少所致。 | ||
| 2022/12 | 2.13 | -1.27 | -27.13 | 27.85 | -22.03 | 5.91 | 1.31 | - | ||
| 2022/11 | 2.16 | 34.04 | -27.56 | 25.71 | -21.58 | 5.9 | 1.31 | - | ||
| 2022/10 | 1.61 | -24.3 | -47.02 | 23.55 | -20.98 | 5.89 | 1.31 | - | ||
| 2022/9 | 2.13 | -1.04 | -30.93 | 21.94 | -18.02 | 6.57 | 1.2 | - | ||
| 2022/8 | 2.15 | -5.87 | -35.48 | 19.81 | -16.34 | 6.78 | 1.16 | - | ||
| 2022/7 | 2.29 | -2.55 | -33.15 | 17.66 | -13.2 | 6.9 | 1.14 | - | ||
| 2022/6 | 2.35 | 3.62 | -33.57 | 15.37 | -9.17 | 7.28 | 1.19 | - | ||
| 2022/5 | 2.26 | -15.19 | -23.12 | 13.03 | -2.74 | 8.12 | 1.06 | - | ||
| 2022/4 | 2.67 | -16.34 | 1.7 | 10.76 | 3.0 | 7.97 | 1.08 | - | ||
| 2022/3 | 3.19 | 51.0 | 1.18 | 8.09 | 3.43 | 8.09 | 1.09 | - | ||
| 2022/2 | 2.11 | -24.23 | -3.31 | 4.9 | 4.95 | 7.83 | 1.12 | - | ||
| 2022/1 | 2.79 | -4.71 | 12.23 | 2.79 | 12.23 | 8.7 | 1.01 | - | ||
| 2021/12 | 2.93 | -1.85 | -7.1 | 35.72 | 34.75 | 8.95 | 0.79 | - | ||
| 2021/11 | 2.98 | -1.96 | 15.87 | 32.79 | 40.4 | 9.11 | 0.78 | - | ||
| 2021/10 | 3.04 | -1.32 | 15.86 | 29.81 | 43.44 | 9.46 | 0.75 | - | ||
| 2021/9 | 3.08 | -7.55 | 14.5 | 26.77 | 47.42 | 9.84 | 0.6 | - | ||
| 2021/8 | 3.34 | -2.47 | 46.77 | 23.68 | 53.16 | 10.29 | 0.58 | 去年同期受新冠肺炎疫情影響,全球需求減少,造成營收銳減 | ||
| 2021/7 | 3.42 | -3.15 | 60.47 | 20.35 | 54.26 | 9.9 | 0.6 | 去年同期受新冠肺炎疫情影響,全球需求減少,造成營收銳減 | ||
| 2021/6 | 3.53 | 19.92 | 145.79 | 16.93 | 53.06 | 9.1 | 0.68 | 去年同期受新冠肺炎疫情影響,全球需求減少,造成營收銳減 | ||
| 2021/5 | 2.94 | 12.18 | 252.09 | 13.39 | 39.21 | 8.72 | 0.71 | 去年同期受新冠肺炎疫情影響,全球需求減少,造成營收銳減 | ||
| 2021/4 | 2.62 | -16.77 | 183.62 | 10.45 | 18.94 | 7.96 | 0.77 | 去年同期受新冠肺炎疫情影響,全球需求減少,造成營收銳減 | ||
| 2021/3 | 3.15 | 44.28 | 14.58 | 7.83 | -0.44 | 7.83 | 0.67 | - | ||
| 2021/2 | 2.19 | -12.04 | -22.76 | 4.67 | -8.54 | 7.82 | 0.67 | - | ||
| 2021/1 | 2.49 | -21.13 | 9.14 | 2.49 | 9.14 | 8.21 | 0.63 | - | ||
| 2020/12 | 3.15 | 22.42 | 16.41 | 26.51 | -19.5 | 8.35 | 0.56 | - | ||
| 2020/11 | 2.57 | -1.96 | 5.11 | 23.35 | -22.72 | 7.89 | 0.59 | - | ||
| 2020/10 | 2.63 | -2.48 | 33.74 | 20.78 | -25.17 | 7.59 | 0.61 | - | ||
| 2020/9 | 2.69 | 18.48 | 17.57 | 18.15 | -29.65 | 7.1 | 0.8 | - | ||
| 2020/8 | 2.27 | 6.62 | -15.22 | 15.46 | -34.25 | 5.84 | 0.97 | - | ||
| 2020/7 | 2.13 | 48.32 | -17.4 | 13.19 | -36.7 | 4.4 | 1.29 | - | ||
| 2020/6 | 1.44 | 71.79 | -39.46 | 11.06 | -39.43 | 3.2 | 1.99 | - | ||
| 2020/5 | 0.84 | -9.63 | -70.59 | 9.62 | -39.42 | 4.51 | 1.41 | 受新冠肺炎疫情影響，全球需求減少，造成營收銳減。 | ||
| 2020/4 | 0.93 | -66.37 | -69.73 | 8.79 | -32.63 | 6.51 | 0.98 | 受新冠肺炎疫情影響，全球需求減少，造成營收銳減 | ||
| 2020/3 | 2.75 | -2.75 | -23.23 | 7.86 | -21.26 | 7.86 | 0.73 | - | ||
| 2020/2 | 2.83 | 24.29 | 10.51 | 5.11 | -20.16 | 7.81 | 0.74 | - | ||
| 2020/1 | 2.28 | -15.88 | -40.64 | 2.28 | -40.64 | 0.0 | N/A | - | ||
| 2019/12 | 2.71 | 10.54 | -10.13 | 32.93 | -19.83 | 0.0 | N/A | - |
